Teriparatide-denosumab combo shows promise for osteoporosis

05/15/2013 | HealthDay News

Combining teriparatide and denosumab was more effective than using the drugs alone in increasing bone density in postmenopausal women with osteoporosis, a small study found. The combination also was more effective than any drugs on the market today, the study author said. The findings appeared online in The Lancet.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA